PATENT CLAIM ANALYSIS

Application Number: 15777290
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The invention provides lentiviral preparations containing a sulfonic acid buffer, such as 1,4-piperazinediethanesulfonic acid (PIPES), 2-(N-morpholino)ethanesulfonic acid (MES), and 3-morpholinopropane-1-sulfonic acid (MOPS), a sodium citrate buffer, or a phosphate buffer. The invention additionally encompasses methods of lentiviral purification as well as methods of transducing human cells.

Claim (Index 18):
The aqueous composition of  claim 1 , wherein said aqueous composition comprises 20 mM PIPES, 75 mM sodium chloride, and 2.5% sucrose by weight per volume of said aqueous composition, and said aqueous composition has a pH of about 6.5.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 93.0
- Lexical Diversity: 1.65789
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15106862', '12443153', '15022049', '13277900', '14412844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739595476933032
- 35 USC 102 Novelty (BERT): 0.5099707579884235
- Combined Prediction Score: 0.7166330050385712
- Mean Citation Score: 254.641716
- Max Citation Score: 258.30765
- Similarity Product: 166.59230935967267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test